Skip to main content
Premium Trial:

Request an Annual Quote

DNA Chip Research Institute, CXR Biosciences, Tecan


The DNA Chip Research Institute has introduced its HyperGene Rat cDNA Chip. The microarray was co-developed by Hitachi Software Engineering and has 500-1,000 PCR-amplified samples spotted on a standard 76x26 mm glass slide. Japan-based DNA Chip Research expects the product to generate sales of 50 million yen ($454,545) annually.

CXR Biosciences has launched an Investigative Toxicology service using transcriptional profiling. The service uses microarray scanning technology from Agilent in quantifying mRNA expression levels. CXR recently gained accreditation from Agilent to act as a certified “Agilent Service Provider.”

Tecan has introduced the LS Reloaded, a series of automation-friendly microarray scanners. The new series is based on the firm’s existing 200/300/400 systems and offers three-fold higher sensitivity.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.